CRISPR Therapeutics AG (CRSP) Other Accumulated Expenses (2015 - 2026)
CRISPR Therapeutics AG (CRSP) recorded Other Accumulated Expenses of $16.98 million in Q2 2026, compared with $604,000 a year earlier and up 29.5% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
At the end of FY2025, CRISPR Therapeutics AG reported Other Accumulated Expenses of $13.11 million, up 25.9% from FY2024.
- Annual Other Accumulated Expenses has increased for three straight years, with a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $10.42 million in FY2024 (+102.6%), $5.14 million in FY2023 (+341.7%), $1.16 million in FY2022 (-8.0%) and $1.27 million in FY2021 (-82.4%).
- The Q2 2026 figure is the highest quarterly Other Accumulated Expenses in data going back to Q4 2015.
- On a year-over-year basis, Other Accumulated Expenses rose in three of the last six quarters, with growth averaging 57.6%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 483.3% in Q3 2024, against a decline of 97.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.11 million (Q1 2026), $13.11 million (Q4 2025) and $563,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | CRISPR Therapeutics AG | 5.36 Bn | 5.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.98 Mn |
| Mar 31, 2026 | 13.11 Mn |
| Dec 31, 2025 | 13.11 Mn |
| Sep 30, 2025 | 563,000.00 |
| Jun 30, 2025 | 604,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | 10.42 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | 5.14 Mn |
| Sep 30, 2023 | 827,000.00 |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 734,000.00 |
| Jun 30, 2022 | 2.48 Mn |
| Mar 31, 2022 | 2.27 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 332,000.00 |
API Access
CRISPR Therapeutics AG Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();